 | • レポートコード：B-GIR09D3955 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エトラビリンの世界市場について調べ、まとめました。種類別セグメントは、25mg錠、100mg錠、200mg錠等、用途別セグメントは、成人、小児患者等に区分しました。エトラビリンの世界市場概観、企業動向、企業別エトラビリンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エトラビリンの市場概観 ・エトラビリンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エトラビリンの企業別販売動向、市場シェア、市場集中度、競争動向 ・エトラビリンの世界市場規模 ・エトラビリンの北米市場分析（アメリカ、カナダ、メキシコ等） ・エトラビリンのアメリカ市場規模推移 ・エトラビリンのカナダ市場規模推移 ・エトラビリンのメキシコ市場規模推移 ・エトラビリンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エトラビリンのドイツ市場規模推移 ・エトラビリンのイギリス市場規模推移 ・エトラビリンのロシア市場規模推移 ・エトラビリンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エトラビリンの日本市場規模推移 ・エトラビリンの中国市場規模推移 ・エトラビリンの韓国市場規模推移 ・エトラビリンのインド市場規模推移 ・エトラビリンの東南アジア市場規模推移 ・エトラビリンの南米市場分析（ブラジル、アルゼンチン等） ・エトラビリンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エトラビリンの種類別分析/販売量、売上、市場シェア（25mg錠、100mg錠、200mg錠） ・エトラビリンの用途別分析/市場規模（成人、小児患者） ・エトラビリンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エトラビリンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine.
Scope of the Report:
The global Etravirine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Etravirine.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Etravirine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Etravirine market by product type and applications/end industries.
Market Segment by Companies, this report covers
Janssen Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
25 mg Tablets
100 mg Tablets
200 mg Tablets
Market Segment by Applications, can be divided into
Adults
Pediatric patients
Table of Contents
1 Etravirine Market Overview
1.1 Product Overview and Scope of Etravirine
1.2 Classification of Etravirine by Types
1.2.1 Global Etravirine Revenue Comparison by Types (2019-2024)
1.2.2 Global Etravirine Revenue Market Share by Types in 2018
1.2.3 25 mg Tablets
1.2.4 100 mg Tablets
1.2.5 200 mg Tablets
1.3 Global Etravirine Market by Application
1.3.1 Global Etravirine Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Etravirine Market by Regions
1.4.1 Global Etravirine Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Etravirine Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Etravirine Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Etravirine Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Etravirine Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Etravirine Status and Prospect (2014-2024)
1.5 Global Market Size of Etravirine (2014-2024)
2 Manufacturers Profiles
2.1 Janssen Therapeutics
2.1.1 Business Overview
2.1.2 Etravirine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Janssen Therapeutics Etravirine Revenue, Gross Margin and Market Share (2017-2018)
3 Global Etravirine Market Competition, by Players
3.1 Global Etravirine Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Etravirine Players Market Share
3.2.2 Top 10 Etravirine Players Market Share
3.3 Market Competition Trend
4 Global Etravirine Market Size by Regions
4.1 Global Etravirine Revenue and Market Share by Regions
4.2 North America Etravirine Revenue and Growth Rate (2014-2019)
4.3 Europe Etravirine Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Etravirine Revenue and Growth Rate (2014-2019)
4.5 South America Etravirine Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Etravirine Revenue and Growth Rate (2014-2019)
5 North America Etravirine Revenue by Countries
5.1 North America Etravirine Revenue by Countries (2014-2019)
5.2 USA Etravirine Revenue and Growth Rate (2014-2019)
5.3 Canada Etravirine Revenue and Growth Rate (2014-2019)
5.4 Mexico Etravirine Revenue and Growth Rate (2014-2019)
6 Europe Etravirine Revenue by Countries
6.1 Europe Etravirine Revenue by Countries (2014-2019)
6.2 Germany Etravirine Revenue and Growth Rate (2014-2019)
6.3 UK Etravirine Revenue and Growth Rate (2014-2019)
6.4 France Etravirine Revenue and Growth Rate (2014-2019)
6.5 Russia Etravirine Revenue and Growth Rate (2014-2019)
6.6 Italy Etravirine Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Etravirine Revenue by Countries
7.1 Asia-Pacific Etravirine Revenue by Countries (2014-2019)
7.2 China Etravirine Revenue and Growth Rate (2014-2019)
7.3 Japan Etravirine Revenue and Growth Rate (2014-2019)
7.4 Korea Etravirine Revenue and Growth Rate (2014-2019)
7.5 India Etravirine Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Etravirine Revenue and Growth Rate (2014-2019)
8 South America Etravirine Revenue by Countries
8.1 South America Etravirine Revenue by Countries (2014-2019)
8.2 Brazil Etravirine Revenue and Growth Rate (2014-2019)
8.3 Argentina Etravirine Revenue and Growth Rate (2014-2019)
8.4 Colombia Etravirine Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Etravirine by Countries
9.1 Middle East and Africa Etravirine Revenue by Countries (2014-2019)
9.2 Saudi Arabia Etravirine Revenue and Growth Rate (2014-2019)
9.3 UAE Etravirine Revenue and Growth Rate (2014-2019)
9.4 Egypt Etravirine Revenue and Growth Rate (2014-2019)
9.5 Nigeria Etravirine Revenue and Growth Rate (2014-2019)
9.6 South Africa Etravirine Revenue and Growth Rate (2014-2019)
10 Global Etravirine Market Segment by Type
10.1 Global Etravirine Revenue and Market Share by Type (2014-2019)
10.2 Global Etravirine Market Forecast by Type (2019-2024)
10.3 25 mg Tablets Revenue Growth Rate (2014-2024)
10.4 100 mg Tablets Revenue Growth Rate (2014-2024)
10.5 200 mg Tablets Revenue Growth Rate (2014-2024)
11 Global Etravirine Market Segment by Application
11.1 Global Etravirine Revenue Market Share by Application (2014-2019)
11.2 Etravirine Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2014-2019)
11.4 Pediatric patients Revenue Growth (2014-2019)
12 Global Etravirine Market Size Forecast (2019-2024)
12.1 Global Etravirine Market Size Forecast (2019-2024)
12.2 Global Etravirine Market Forecast by Regions (2019-2024)
12.3 North America Etravirine Revenue Market Forecast (2019-2024)
12.4 Europe Etravirine Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Etravirine Revenue Market Forecast (2019-2024)
12.6 South America Etravirine Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Etravirine Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Etravirine Picture
Table Product Specifications of Etravirine
Table Global Etravirine and Revenue (Million USD) Market Split by Product Type
Figure Global Etravirine Revenue Market Share by Types in 2018
Figure 25 mg Tablets Picture
Figure 100 mg Tablets Picture
Figure 200 mg Tablets Picture
Table Global Etravirine Revenue (Million USD) by Application (2014-2024)
Figure Etravirine Revenue Market Share by Applications in 2018
Figure Adults Picture
Figure Pediatric patients Picture
Table Global Market Etravirine Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Etravirine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Etravirine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Etravirine Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Etravirine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Etravirine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Etravirine Revenue (Million USD) and Growth Rate (2014-2024)
Table Janssen Therapeutics Basic Information, Manufacturing Base and Competitors
Table Janssen Therapeutics Etravirine Type and Applications
Table Janssen Therapeutics Etravirine Revenue, Gross Margin and Market Share (2017-2018)
Table Global Etravirine Revenue (Million USD) by Players (2014-2019)
Table Global Etravirine Revenue Share by Players (2014-2019)
Figure Global Etravirine Revenue Share by Players in 2017
Figure Global Etravirine Revenue Share by Players in 2018
Figure Global Top 5 Players Etravirine Revenue Market Share in 2018
Figure Global Top 10 Players Etravirine Revenue Market Share in 2018
Figure Global Etravirine Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Etravirine Revenue (Million USD) by Regions (2014-2019)
Table Global Etravirine Revenue Market Share by Regions (2014-2019)
Figure Global Etravirine Revenue Market Share by Regions (2014-2019)
Figure Global Etravirine Revenue Market Share by Regions in 2018
Figure North America Etravirine Revenue and Growth Rate (2014-2019)
Figure Europe Etravirine Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Etravirine Revenue and Growth Rate (2014-2019)
Figure South America Etravirine Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Etravirine Revenue and Growth Rate (2014-2019)
Table North America Etravirine Revenue by Countries (2014-2019)
Table North America Etravirine Revenue Market Share by Countries (2014-2019)
Figure North America Etravirine Revenue Market Share by Countries (2014-2019)
Figure North America Etravirine Revenue Market Share by Countries in 2018
Figure USA Etravirine Revenue and Growth Rate (2014-2019)
Figure Canada Etravirine Revenue and Growth Rate (2014-2019)
Figure Mexico Etravirine Revenue and Growth Rate (2014-2019)
Table Europe Etravirine Revenue (Million USD) by Countries (2014-2019)
Figure Europe Etravirine Revenue Market Share by Countries (2014-2019)
Figure Europe Etravirine Revenue Market Share by Countries in 2018
Figure Germany Etravirine Revenue and Growth Rate (2014-2019)
Figure UK Etravirine Revenue and Growth Rate (2014-2019)
Figure France Etravirine Revenue and Growth Rate (2014-2019)
Figure Russia Etravirine Revenue and Growth Rate (2014-2019)
Figure Italy Etravirine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Etravirine Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Etravirine Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Etravirine Revenue Market Share by Countries in 2018
Figure China Etravirine Revenue and Growth Rate (2014-2019)
Figure Japan Etravirine Revenue and Growth Rate (2014-2019)
Figure Korea Etravirine Revenue and Growth Rate (2014-2019)
Figure India Etravirine Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Etravirine Revenue and Growth Rate (2014-2019)
Table South America Etravirine Revenue by Countries (2014-2019)
Table South America Etravirine Revenue Market Share by Countries (2014-2019)
Figure South America Etravirine Revenue Market Share by Countries (2014-2019)
Figure South America Etravirine Revenue Market Share by Countries in 2018
Figure Brazil Etravirine Revenue and Growth Rate (2014-2019)
Figure Argentina Etravirine Revenue and Growth Rate (2014-2019)
Figure Colombia Etravirine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Etravirine Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Etravirine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Etravirine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Etravirine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Etravirine Revenue and Growth Rate (2014-2019)
Figure UAE Etravirine Revenue and Growth Rate (2014-2019)
Figure Egypt Etravirine Revenue and Growth Rate (2014-2019)
Figure Nigeria Etravirine Revenue and Growth Rate (2014-2019)
Figure South Africa Etravirine Revenue and Growth Rate (2014-2019)
Table Global Etravirine Revenue (Million USD) by Type (2014-2019)
Table Global Etravirine Revenue Share by Type (2014-2019)
Figure Global Etravirine Revenue Share by Type (2014-2019)
Figure Global Etravirine Revenue Share by Type in 2019
Table Global Etravirine Revenue Forecast by Type (2019-2024)
Figure Global Etravirine Market Share Forecast by Type (2019-2024)
Figure Global 25 mg Tablets Revenue Growth Rate (2014-2019)
Figure Global 100 mg Tablets Revenue Growth Rate (2014-2019)
Figure Global 200 mg Tablets Revenue Growth Rate (2014-2019)
Table Global Etravirine Revenue by Application (2014-2019)
Table Global Etravirine Revenue Share by Application (2014-2019)
Figure Global Etravirine Revenue Share by Application (2014-2019)
Figure Global Etravirine Revenue Share by Application in 2019
Table Global Etravirine Revenue Forecast by Application (2019-2024)
Figure Global Etravirine Market Share Forecast by Application (2019-2024)
Figure Global Adults Revenue Growth Rate (2014-2019)
Figure Global Pediatric patients Revenue Growth Rate (2014-2019)
Figure Global Etravirine Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Etravirine Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Etravirine Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Etravirine Revenue Market Forecast (2019-2024)
Figure Europe Etravirine Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Etravirine Revenue Market Forecast (2019-2024)
Figure South America Etravirine Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Etravirine Revenue Market Forecast (2019-2024)
世界のアルモダフィニル市場予測（～2024年） Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil. Scope of the Report: The global Armodafinil market is valued at xx million USD in 2018 and is expected to reach xx million USD by th…- 世界のルフィナミド市場予測（～2024年） Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Scope of the Report: The global Rufinamide market is valued at xx million USD in 2018 and is expected to reach xx million USD …
- スタイラス付きタブレット市場：世界及び中国市場分析・予測（～2024年） Tablets with Stylus Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Tablets with Stylus industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tablets with Stylus manufactur…
- メディアタブレット市場：世界及び中国市場分析・予測（～2024年） Media Tablets Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Media Tablets industry with a focus on the Chinese market. The report provides key statistics on the market status of the Media Tablets manufacturers and is a valua…
- 錠剤及びカプセルパッケージング市場：世界及び中国市場分析・予測（～2024年） Tablets and Capsules Packaging Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Tablets and Capsules Packaging industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tablets …